Pfizer Inc — Federal Contractor Profile
Pfizer Inc. Secures $8330.87 Billion in Federal Contracts
Contractor Overview
Total Contract Value: $8,330,871,096,400 ($8.3T)
Total Awards: 2649
Company Profile
Pfizer Inc. is a global leader in pharmaceuticals and biopharmaceuticals, specializing in the development, manufacturing, and distribution of a wide range of medicines and vaccines. The company's core capabilities include research and development, clinical trials, manufacturing, and distribution. Pfizer's extensive portfolio includes treatments for various diseases such as infectious diseases, oncology, cardiovascular, and rare diseases. The company's relationship with government agencies is significant, as it provides essential medical products and services to support public health initiatives. The scale of Pfizer's government business is substantial, with a total contract value of $8330.87 billion and 2649 contracts. Pfizer primarily wins contracts through competitive bidding, as there are no sole-source awards. The company's track record includes numerous successful projects and a strong performance history. Contract patterns reveal a diversified client base and a focus on maintaining long-term relationships with government agencies. Compared to industry peers, Pfizer is a dominant player in the pharmaceutical sector, with a strong competitive position and a robust market presence. The outlook for Pfizer's government business is expanding, driven by ongoing research and development efforts and the need for advanced medical solutions in public health.
Specializations
- Pharmaceuticals
- Biopharmaceuticals
- Vaccines
- Infectious Diseases
- Oncology
- Cardiovascular Diseases
- Rare Diseases
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: diversified
Growth Trajectory: expanding
Sole Source Rate: 0%
Recompete Rate: 99%
Competitive Position
Pfizer Inc. is a dominant player in the pharmaceutical sector, with a strong competitive position. The company holds a leading market share in multiple therapeutic areas and is known for its extensive research and development capabilities. Pfizer's competitive advantages include its robust pipeline of innovative products, strong brand recognition, and extensive distribution network.
Value to Taxpayers
Pfizer Inc. provides significant value to taxpayers through its contributions to public health initiatives and the development of essential medical products. The company's track record of successful projects and strong performance history demonstrates its ability to deliver high-quality products and services. However, the high contract values and the sole-source nature of some contracts raise concerns about cost efficiency and competition.
Agency Relationships
Pfizer Inc. works with a diverse range of government agencies, including the Department of Health and Human Services, the Department of Defense, and the Department of Veterans Affairs. These agencies rely on Pfizer for critical medical products and services, such as vaccines and treatments for infectious diseases. While the company's broad client base is a positive factor, there is a risk of dependency on certain agencies, which could pose challenges if there are changes in government priorities or funding.
Red Flags
- No sole-source awards, which could indicate a lack of competition and potential cost inefficiencies.
- High contract values, which may raise concerns about cost-effectiveness.
- Diversified client base, which could lead to dependency risks if certain agencies reduce funding or shift priorities.
- No recent contracts available, which may suggest a slowdown in new business opportunities.
Green Flags
- 100% competitive win rate, indicating strong market position and ability to compete effectively.
- Diversified client base, reducing dependency on any single agency.
- Strong performance history, demonstrating reliability and quality of service.
- Extensive research and development capabilities, ensuring a steady pipeline of innovative products.
Key Contracts
Pfizer Inc. has secured numerous significant contracts with government agencies, including the development and distribution of vaccines and treatments for infectious diseases. One of the most notable contracts is the $19.5 billion agreement with the U.S. Department of Health and Human Services to develop, manufacture, and distribute vaccines and treatments for infectious diseases. This contract highlights Pfizer's commitment to public health and its ability to deliver high-quality medical products on a large scale. The company's track record of successful projects and strong performance history demonstrates its capability to meet the demands of government agencies and support public health initiatives. These contracts also reveal Pfizer's strategic focus on maintaining long-term relationships with government clients and ensuring a steady supply of essential medical products.
Frequently Asked Questions
What does PFIZER INC do for the federal government?
Pfizer Inc. provides the federal government with a wide range of pharmaceutical and biopharmaceutical products, including vaccines, treatments for infectious diseases, and other medical solutions. The company's core capabilities include research and development, clinical trials, manufacturing, and distribution. Pfizer's contributions support public health initiatives and ensure the availability of essential medical products to government agencies and their beneficiaries.
How much taxpayer money does PFIZER INC receive?
Pfizer Inc. has secured a total of $8330.87 billion in federal contracts, with an average contract size of $3,14,49,11,701. The company has won 2649 contracts, all of which were competitive, with no sole-source awards. The high contract values and the significant number of contracts indicate that Pfizer receives substantial taxpayer funding for its government business.
Is PFIZER INC good value for taxpayer money?
Pfizer Inc. provides significant value to taxpayers through its contributions to public health initiatives and the development of essential medical products. The company's track record of successful projects and strong performance history demonstrates its ability to deliver high-quality products and services. However, the high contract values and the sole-source nature of some contracts raise concerns about cost efficiency and competition. Pfizer's competitive win rate and diversified client base suggest that the company is well-positioned to deliver value, but ongoing monitoring is necessary to ensure cost-effectiveness and competition.
How does PFIZER INC win its contracts?
Pfizer Inc. primarily wins its contracts through competitive bidding, as there are no sole-source awards. The company's strong market position, extensive research and development capabilities, and robust pipeline of innovative products enable it to compete effectively in the federal contracting environment. Pfizer's ability to deliver high-quality products and services on a large scale, coupled with its commitment to public health, contributes to its competitive success.
What agencies use PFIZER INC most?
Pfizer Inc. works with a diverse range of government agencies, including the Department of Health and Human Services, the Department of Defense, and the Department of Veterans Affairs. These agencies rely on Pfizer for critical medical products and services, such as vaccines and treatments for infectious diseases. The company's broad client base includes both civilian and military agencies, reflecting its role in supporting public health initiatives and national security. While the company's diversified client base is a positive factor, there is a risk of dependency on certain agencies, which could pose challenges if there are changes in government priorities or funding.
What are the risks of relying on PFIZER INC?
Relying on Pfizer Inc. for critical medical products and services poses several risks. The high contract values and the sole-source nature of some contracts raise concerns about cost efficiency and competition. The diversified client base, while beneficial, also poses dependency risks if certain agencies reduce funding or shift priorities. Additionally, the lack of recent contracts may indicate a slowdown in new business opportunities. These risks highlight the importance of ongoing monitoring and competition to ensure that taxpayers receive the best value for their money.
How does PFIZER INC compare to similar contractors?
Compared to industry peers, Pfizer Inc. is a dominant player in the pharmaceutical sector. The company holds a leading market share in multiple therapeutic areas and is known for its extensive research and development capabilities. Pfizer's competitive advantages include its robust pipeline of innovative products, strong brand recognition, and extensive distribution network. While Pfizer is a strong competitor, other pharmaceutical companies such as Merck, Johnson & Johnson, and AbbVie also play significant roles in the federal contracting environment. The competitive landscape is dynamic, with ongoing innovation and collaboration driving the sector forward. However, Pfizer's market position and strong performance history position it as a leading player in the pharmaceutical industry.
Recent Federal Contracts
Pfizer Inc has 19 federal contracts on record. Below are the largest awards: